Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Tech Today.
Press releases published on September 5, 2025

XPPen Debuts the Artist Ultra 16, Introducing a New Series with Industry-Leading Touch Screen Technology at IFA 2025
BERLIN, Sept. 05, 2025 (GLOBE NEWSWIRE) -- XPPen, the world’s leading digital art innovation brand, opened its presence at IFA 2025 in Berlin (Booth H5.2-197) with the world premiere of its upcoming flagship innovation Artist Ultra 16. This new-generation …

Adagene’s ADG126 to be Highlighted in Two Presentations at the 2025 Chinese Society of Clinical Oncology (CSCO) Meeting in Jinan, China
SAN DIEGO and SUZHOU, China, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene or the Company”) (Nasdaq: ADAG), a company transforming the discovery and development of novel antibody-based therapies, today announced that ADG126 will be highlighted …

iFLYTEK Launches AINOTE Air 2 in Europe: Redefining Productivity with AI-Powered E-Ink Technology
FRANKFURT, Germany, Sept. 05, 2025 (GLOBE NEWSWIRE) -- iFLYTEK today announced the launch of its latest E-Ink tablet, AINOTE Air 2, in the European market through joint marketing with Joybuy. With this launch, the Air 2 introduces German and Spanish system …

World of Dypians Goes Gold with 1M YouTube Subscribers and Launch on Binance Alpha
Road Town, Tortola, BVI, Sept. 05, 2025 (GLOBE NEWSWIRE) -- World of Dypians ($WOD), a revolutionary MMORPG available on Epic Games, has received the YouTube Gold Award for surpassing 1 million subscribers on the platform. WoD is the first Web3 gaming …

MAIA Biotechnology Abstract Selected for Poster Presentation at 2025 IASLC World Conference on Lung Cancer
Poster details durability and efficacy of ateganosine (THIO) treatment in non-small cell lung cancer (NSCLC) CHICAGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage …

Robot Consulting Co., Ltd. Engages Former bitFlyer Holdings CEO Masaaki Seki as to Advise on Ethereum Investment Strategy and Finance
Tokyo, Japan, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Robot Consulting Co., Ltd. (Nasdaq: LAWR) (the “Company” or “Robot Consulting”), a Japanese platform service provider focusing on human resource solutions with an intention to expand into legal technology …

Mineralys Therapeutics Presents Subgroup Analyses of Phase 3 Launch-HTN Trial Demonstrating Efficacy and Safety of Lorundrostat in Hypertension Participants with High Unmet Medical Need
~Pivotal Launch-HTN trial of novel aldosterone synthase inhibitor lorundrostat enrolled a diverse range of participants with uncontrolled or resistant hypertension~ ~Subgroups - including Black or African American adults, older adults, women, and …

Palisade Bio Receives Health Canada Clearance for Phase 1b Trial of PALI-2108 in Fibrostenotic Crohn’s Disease (FSCD)
First dual-acting anti-inflammatory and anti-fibrotic candidate in development for FSCD, a condition with no approved therapies Patient dosing expected to commence in H2 2025; Topline data anticipated in Q1 2026 Continued progress toward Phase 2 IND …

Orbit International Reports Consolidated Bookings of Approximately $2,400,000 for Month of August
HAUPPAUGE, N.Y., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Orbit International Corp. (the “Company”) (OTCID Basic Market:ORBT), an electronics manufacturer and software solution provider, today announced that for the month of August 2025, consolidated bookings …

Cellectar Biosciences to Participate in Multiple Upcoming Medical Meetings and Industry Conferences in September
FLORHAM PARK, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced that Jarrod …

Banzai Completes $32.7 Million Debt and Liability Elimination Through August 31, 2025
$10.7 Million Repaid Year to Date and $32.7 Million Since September 2024 Obligation Debt Reduction Initiatives Adding Material Benefit to Net Income and Shareholders’ Equity SEATTLE, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Banzai International, Inc. (NASDAQ: …

Tiziana Life Sciences Announces Purchase of Shares by Chairman
BOSTON, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …

24/7 Market News: Kraig Labs Fibers are 5X Stronger Than Steel, Tougher than Kevlar, and Biodegradable
DENVER, Sept. 05, 2025 (GLOBE NEWSWIRE) -- 247marketnews.com, a pioneer in digital media dedicated to the swift distribution of financial market news and insights, reports that Kraig Biocraft Laboratories (OTCQB: KBLB)(“Kraig Labs” or “the Company”), the …

Lowkick Studio Launches $SHARDS as WorldShards Expands to Global Audiences
Abu Dhabi, UAE, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Lowkick Studio has officially announced the launch of the $SHARDS token, the core of its upcoming Web3 MMORPG, WorldShards. The token generation event (TGE) coincides with listings on top-tier exchanges, …

Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRISBANE, Calif., Sept. 05, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies to transform the lives of patients, today announced the granting of inducement awards …

electroCore Announces Departure of Peter Cuneo from the Board of Directors and Elects Thomas J. Errico, MD as Chairman of the Board
ROCKAWAY, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the departure of Peter Cuneo from the Board of Directors and that Thomas J. Errico, MD, has …

Taysha Gene Therapies Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
DALLAS, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of …

Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025
– 17 abstracts accepted, including one oral presentation – – Data from the REFRESH real-world study highlight efficacy of once-nightly sodium oxybate when switching from twice-nightly oxybates – – REFRESH study also highlights efficacy in those who were …

Geotab atinge 5 milhões de veículos conectados globalmente e reforça liderança em telemática
SÃO PAULO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- A Geotab anunciou a conquista de um novo marco: alcançou a marca de mais de 5 milhões de veículos conectados globalmente, reforçando sua liderança em telemática e soluções para o setor de transportes. O …

Youxin Technology Ltd Announces Pricing of $6.0 Million Underwritten Public Offering
GUANGZHOU, CHINA, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Youxin Technology Ltd (NASDAQ: YAAS) (the “Company”), a software as a service (“SaaS”) and platform as a service (“PaaS”) provider committed to helping retail enterprises digitally transform their …